News

Spiraling Costs Threaten Gridlock

+ See all authors and affiliations

Science  10 Oct 2008:
Vol. 322, Issue 5899, pp. 210-213
DOI: 10.1126/science.322.5899.210

You are currently viewing the summary.

View Full Text

Summary

The gold standard of medical science--the big randomized trial--is in danger of being priced out of reach by technical complexity, poor management, and paperwork.